The role of circadian clock genes in mental disorders by Waddington Lamont, Elaine et al.
he role of the endogenous circadian system is to
coordinate the body’s functions with each other and with
the external environment.
1This includes the integration
of sensory information and environmental time cues,and
of the organism’s physiological and psychological states.
When the harmony of this integrative function is per-
turbed,as could be the case with several mental disorders,
disturbances of mood,a disrupted sleep-wake cycle,and
changes in levels and/or timing of hormones can occur.
Whether these changes precede, follow, or are epiphe-
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The study of molecular clock mechanisms in psychiatric disorders is gaining significant interest due to data suggesting
that a misalignment between the endogenous circadian system and the sleep-wake cycle might contribute to the clin-
ical status of patients suffering from a variety of psychiatric disorders. Sleep disturbances in major depressive disorder
(MDD) are characterized by increased sleep latency, poorer sleep efficiency, reduced latency to the first rapid eye move-
ment (REM) sleep episode, and early-morning awakening, but there is little data to indicate a role of circadian clock
genes in MDD. There is also relatively little information regarding the role of clock genes in anxiety. In contrast, a sig-
nificant amount of evidence gathered in bipolar disorder (BPD) patients suggests a circadian rhythm disorder, namely
an advanced circadian rhythm and state-dependent alterations of REM sleep latency. Most research on the role of
clock genes in BPD has focused on polymorphisms of CLOCK, but the lithium target GSK3 may also play a significant
role. A circadian phase shift is also theorized to contribute to the pathophysiology of winter seasonal affective dis-
order (SAD). Certain allelic combinations of NPAS2, PER3, and BMAL1 appear to contribute to the risk of SAD. In chronic
schizophrenia, disturbances of sleep including insomnia and reduced sleep efficiency have been observed. Genetic
studies have found associations with CLOCK, PER1, PER3, and TIMELESS. Sleep and circadian changes associated with
dementia due to Alzheimer’s disease suggest a functional change in the circadian master clock, which is supported by
postmortem studies of clock gene expression in the brain.
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mine with certainty, although several lines of evidence
support a role of the endogenous circadian system in the
pathophysiology of these disorders.The purpose of this
review is to describe sleep and circadian rhythm distur-
bances in mental disorders and to summarize current
research on the role of clock genes in several psychiatric
disorders.
Molecular mechanism of circadian rhythmicity
Circadian rhythmicity is a consequence of intracellular
molecular mechanisms involving so-called clock genes.
The products of some of these clock genes regulate their
own expression,and the outcome of this feedback loop
is an oscillation in the levels of messenger ribonucleic
acids (mRNAs) and proteins.These mRNA and protein
rhythms are observed in the suprachiasmatic nucleus
(SCN) of the hypothalamus,the master clock,as well as
in other brain regions and peripheral tissues.Within the
clock,other factors control the phosphorylation,stabil-
ity,and localization of clock proteins,thereby regulating
the oscillation,particularly the period.
In mammals,Clock and Bmal1 encode transcription fac-
tors CLOCK and BMAL1 (brain and muscle ARNT-like
protein 1; also known as ARNTL or MOP3),
2-4 which
form heterodimers that activate the transcription of three
Period genes (PER1, 2 and 3) and two Cryptochrome
genes (CRY1 and 2),
5-7 Ror and Rev-Erb
8-10 (Figure 1).
PER and CRY proteins form complexes
11 that are
translocated back into the nucleus and inhibit their own
expression.
5,7,12-15 RORα and REV-ERBα act on Bmal1 to
activate and repress transcription respectively
.8,9 NPAS2
is an alternate dimerization partner for BMAL1 that may
also regulate circadian rhythmicity in the forebrain,but
it has not been consistently found in the SCN.
16,17 Clock
proteins are phosphorylated by casein kinase I epsilon
(CKIε) and delta (CKIδ), and possibly also by the
Drosophila shaggy homologue glycogen synthase kinase
3 (GSK3).
18They are targeted for degradation by com-
ponents of ubiquitin ligase complexes like FBXL3 and
β-TRCP1,
19,20 which together regulate the period of cir-
cadian oscillation by controlling the rate of accumulation,
association and translocation of PER and CRY.
11,15,21-23
These genes, protein products, and enzymes work
together to control clock functioning,and abnormalities
such as clock gene mutations can have profound conse-
quences for the synchronization of emotional, physio-
logical,and behavioral processes with each other and the
environment. Examples of the sometimes dramatic
effects of clock gene polymorphisms in nonpsychiatric
disorders are described, followed by a description of
recent research on clock genes in mental disorders.
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Selected abbreviations and acronyms
AD Alzheimer's disease
ASPD advanced sleep phase disorder
BPD bipolar disorder
CBT core body temperature
DSPD delayed sleep phase disorder
FASPD familial advanced sleep phase disorder
GSK glycogen synthase kinase
MDD Major Depressive Disorder
mRNA messenger ribonucleic acid
REM rapid eye movement
SAD seasonal affective disorder
SCN suprachiasmatic nucleus
SNP single nucleotide polymorphism
Figure 1. Simplified schematic diagram of the molecular mechanisms of
the circadian clock in mammals. See the main text for details.
Positive and negative feedbacks are indicated by arrows with
a + and a - sign, respectively. Genes and messenger ribonucleic
acid (mRNA) are indicated by italics, proteins are in bold caps.
C = CLOCK protein; N = NPAS2 protein; B = BMAL1 protein
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CryRole of circadian clock genes
in disorders of the sleep-wake cycle
The evidence linking mutations of circadian clock genes
and nonpsychiatric sleep/circadian related disorders is
compelling.In fact,one of the first demonstrations of a
disorder directly related to the human molecular clock
was a polymorphism of human PER2
24 identified in a
family diagnosed with familial advance sleep phase dis-
order (FASPD).
25The resulting amino acid change in the
PER2 protein affects its phosphorylation by CKIδ/ε,and
its stability and intracellular localization,hence the short
period and advanced sleep phase of the patients.
26,27
Interestingly,in another FASPD family,a mutation was
found in the gene encoding CKIδ.
28
A number of studies have focused on a polymorphism in
the human PER3 gene.In one study,this polymorphism
was found to be associated with delayed sleep phase dis-
order (DSPD).
29,30 PER3 variants have also been associ-
ated with morning-evening preference,in this study,pos-
sibly through an effect on sleep structure, but not
circadian timing.Viola and colleagues
31 found that indi-
viduals homozygous for the PER3
5 allele showed marked
differences in sleep compared with those homozygous for
PER3,
4 including greater sleep propensity, increased
slow-wave sleep (SWS) and greater susceptibility to the
effects of sleep deprivation. However, the circadian
rhythms of melatonin,cortisol,and activity were similar
in both groups.
31This suggests that different clock genes
may affect chronotype, either via direct effects on the
clock,or through other mechanisms such as sleep home-
ostasis.
Polymorphism of the human CLOCK gene has also been
associated with evening preference and delayed timing
of the sleep-wake cycle
32,33 (but there are also conflicting
results
34). Subjects carrying one or two copies of the
CLOCK 3111C allele showed increased eveningness and
reduced morningness, while 3111T/T subjects showed
higher morningness scores.
32,33 Although the 3111C/C
genotype is also associated with delayed sleep timing and
greater daytime sleepiness in a Japanese population,
33
thus far there is insufficient evidence to draw the same
conclusions in Caucasians.
32 There is currently no evi-
dence to support an association between the 3111C/C
genotype and DSPD.
34,35
There is evidence to suggest that evening chronotype
could increase the risk of psychiatric disorders.
36 Both
bipolar disorder (BPD) and schizophrenia/schizoaffec-
tive patients show greater eveningness scores than con-
trols.In BPD this observation appears to be correlated
with age (ie,younger BPD patients were more extreme
“evening types”), while schizophrenia/schizoaffective
subjects tended to show greater eveningness at all ages.
Being classified as an “evening type”could account for
some of the sleep disturbances reported by BPD
patients
36 and could increase the severity of BPD as evi-
denced by an earlier age at onset of treatment,greater
likelihood of self-reported rapid mood swings,and rapid-
cycling mood changes.
36 
Some work suggests there may be a relationship between
DSPD and personality disorder.
37 In one study,16% of
institutionalized mentally ill adolescents were also diag-
nosed with DSPS,
38 as compared with 7.3% of adoles-
cents in Western countries.
37 In these adolescents, the
diagnoses tended to include an affective component,such
as bipolar affective, schizoaffective or borderline per-
sonality disorder. Again, this suggests a relationship
between circadian and psychiatric disorders, although
whether one precedes the other or they co-occur is diffi-
cult to determine.
Sleep, circadian clock genes,
and mental disorders
Major Depressive Disorder
Sleep disturbances,particularly insomnia,are an impor-
tant symptom of Major Depressive Disorder (MDD).
39-42
Between 80% and 90% of depressed patients report
insomnia,and insomnia is also a risk factor for develop-
ing depression.
39-41 Sleep disturbances are associated with
impaired quality of life
43 and a greater risk of relapse.
44,45
Reduced rapid eye movement (REM) sleep latency
(RL), an earlier distribution of REM sleep during the
night,and early-morning awakening suggest a possible
phase advance of the endogenous circadian system.
46,47
This hypothesis is further supported by the therapeutic
success of sleep phase advance therapy in depressed
patients.
48 Higher core body temperature (CBT),
49 higher
cortisol 
50-53 and lower melatonin secretion
54,55 have been
observed in depressed patients,supporting an involve-
ment of the circadian system, although contradictory
results exist,
54,56-58 (see refs 46 and 47 for reviews).
To date there has been no evidence of clock gene muta-
tions associated with MDD.The T3111C polymorphism
of CLOCK was investigated, based on its association
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frequencies between a group of 143 people with a his-
tory of major depression and 195 controls.
59 However,
there has been some recent evidence suggesting that
electroconvulsive therapy and antidepressant medica-
tions targeting the dopaminergic and serotonergic neu-
rotransmitter systems, including, monoamine oxidase
inhibitors (MAOIs), fluoxetine, imipramine, clozapine,
risperidone,and haloperidol may have a common mode
of action either via the direct inhibition or increased
phosphorylation of the GSK3 enzyme.
60 GSK3 is
involved in many cellular functions; therefore the ther-
apeutic action may be via a number of possible routes,
including regulation of monaminergic signaling, neuro-
protection, neuroplasticity, modulation of estrogen and
glucocorticoid activity, regulation of brain metabolism,
or regulation of the circadian system.
60This is described
in more detail in the section on BPD below.
Anxiety disorders
Individuals suffering from an anxiety disorder frequently
experience sleep disturbances such as insomnia. Sleep
disorders are common in both generalized anxiety dis-
order (GAD) and post-traumatic stress disorder (PTSD),
and PTSD patients frequently experience nightmares,
and reduced REM sleep.
61There is relatively little evi-
dence suggesting specific circadian disturbances or a role
for clock genes in anxiety disorders.This is perhaps not
surprising,given the heterogeneity of anxiety disorders
and their comorbidity with other disorders such as
depression.
61 In contrast to studies in humans,there are
a few interesting results from research on animals.One
study showed a reduction of Per1 mRNA levels in mouse
cerebellum by antianxiety medications,
62 suggesting that
altering circadian clock gene levels could theoretically
contribute to the therapeutic action of these drugs.Also
of interest is the observed reduction in anxiety observed
in mice with a mutation of the Clock gene.For example,
Clock mutant animals are much more likely to spend
time in open spaces,which normal mice avoid.
63 However,
as these mice also showed behaviors associated with
mania,it is unclear how to best classify this phenotype.
Bipolar disorder
Sleep disturbances have been observed in BPD and often
precede relapses into depression or mania.
46,64-67 Insomnia
or hypersomnia, early-morning awakenings, reduced
sleep efficiency, and reduced RL are the most consis-
tently reported changes.Irregularities in the sleep-wake
cycle and daily activities can be important contributing
factors in mood disruption.
68The relationship between
the sleep-wake cycle and changes in mood appears to be
important in patients with frequent and rapid changes in
mood state,so-called “rapid cyclers,”with the switch from
mania/hypomania to depression/euthymia occurring dur-
ing or after sleep,while positive changes in mood from
depression to hypomania/mania are more likely to occur
after a period of wakefulness.
69,70 Circadian disturbances
have been reported in BPD that suggest a phase advance
of the master clock, including a phase advance of the
diurnal rhythm of plasma cortisol,
71 although negative
results have been reported.
72
Much of the work attempting to link BPD to clock genes
has focused on the 3111T/C polymorphism of the human
CLOCK gene.
73-76 The C/C allele of CLOCK has been
associated with greater severity of insomnia during anti-
depressant treatment
76 and a higher recurrence rate of
bipolar episodes,
74 and reduced need for sleep.
75 Support
for a role of Clock mutation in BPD has recently come
from the animal literature, where behavioral studies
using CLOCK mutant mice suggest a phenotype similar
to mania,with an increase in the reward value of appet-
itive stimuli and reduced depressive and anxiety-like
behaviors.
63
An analysis of 46 single nucleotide polymorphisms (SNP)
in eight clock genes (BMAL1,CLOCK,PER 1,2,3,CRY
1,2,TIMELESS) using family-based samples with BPD
or schizophrenia has been reported.
77A Mendelian trans-
mission distortion analysis revealed association of
BMAL1 (ARNTL) and TIMELESS with BPD.
However,these were modest associations found using a
very liberal analysis.Interestingly,an independent study
using haplotype analysis seems to confirm the association
with BMAL1 (ARNTL) and also finds one with PER3
(TIMELESS was not studied).
78 Studies examining other
genes have found negative results:screening for human
PER2 mutations at the CKIδ/ε binding site showed no
difference in frequency between BPD patients and con-
trols,
79 nor is there any evidence for linkage or associa-
tion of CRY1.
80
Although it has been known for many years that lithium
is effective as a mood stabilizer, its pharmacological
mode of action has remained uncertain.
60 However,
recent evidence suggests that the therapeutic action of
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clock.For example,lithium has been shown to lengthen
the period of circadian rhythms in rodents,
81 and can
lengthen the period of neuronal firing of cultured SCN
neurons in a dose-dependent manner.
82 A delay of the
circadian rhythm of temperature and of REM sleep has
also been shown in a BPD patient.
83This suggests that the
therapeutic action of lithium could be due,in part,to cor-
recting a phase advance of the circadian system related
to the illness.
One proposed molecular mechanism is via the inhibition
of GSK3.
18,84Although this enzyme has a number of func-
tions that could potentially mediate the therapeutic
effects of lithium,
85 one likely possibility is via its function
as a central regulator of the circadian clock.
60 Numerous
lines of evidence support this idea; both lithium and
GSK3 knockdown produce a lengthening of mPer2
period in mouse fibroblasts,
86 and GSK3 phosphorylates
PER2 and REV-ERBα and regulates their localization
and stability,respectively.
18,84 Even more interesting are
findings that inhibition of GSK3 may be common to other
mood-stabilizing agents such as valproate,and may even
be a target of antidepressant therapies,including drugs
which target the serotonergic and dopaminergic systems
as well as electroconvusive therapy.
60 There is also evi-
dence for effects of allelic frequency of the GSK3 -50
T/C SNP.Bipolar patients with the T/T allele of GSK3
show an earlier age on onset of bipolar disorder and enjoy
less improvement from lithium therapy than patients with
the T/C or C/C alleles.
87,88Together these results are per-
suasive,making GSK3 a promising target for the future
development of pharmotherapeutic agents.
Seasonal affective disorder
Seasonal affective disorder (SAD) patients frequently
have sleep complaints, particularly hypersomnia, with
longer polysomnographically-recorded non-REM
(NREM) sleep and greater slow-wave activity per
minute of NREM sleep.
89A chronobiological hypothesis
of SAD has been suggested for a while.
90,91The phase shift
hypothesis postulates that SAD patients become
depressed in winter because there is a season-specific
shift in their endogenous circadian system with respect
to their sleep-wake cycle.
90 Bright light exposure and/or
exogenous melatonin have been used successfully to cor-
rect this phase shift.
92
Recent studies suggest that polymorphisms of
PERIOD2, NPAS2, and BMAL1 (ARNTL) could be
associated with an increased risk for SAD.These three
clock genes were analyzed for SNPs in a sample of 189
SAD patients and an equal number of matched controls.
Specifically, polymorphisms of BMAL1, PER2, and
NPAS2 are associated with SAD, but together, certain
allelic combinations of SNPs of these three genes have
an additive effect,increasing the risk of developing SAD
by 4.43 over other genotypes, and 10.67 over the most
protective genotype.
93An association of the same leucine
allele for NPAS2 471 had been reported previously.
94 In
addition,this study supported a relationship between the
PER3 647 Val/Gly genotype and morningness /evening-
ness,particularly in the SAD group.
94This reinforces the
suggestion of an association between certain clock gene
polymorphisms and chronotype.Also,it suggests that cer-
tain abnormalities in the circadian molecular clock
increase the susceptibility to SAD.
Schizophrenia
Sleep abnormalities have been consistently found in
schizophrenia, although the results have not been con-
sistent across studies.
95These include insomnia,reduced
total sleep time (TST), increased sleep latency, poor
sleep consolidation and sleep efficiency, and low levels
of SWS, with insomnia frequently signaling relapse.
96
Actigraphic recordings of schizophrenic patients have
revealed disturbed rest-activity cycles, showing either
phase delays, longer periods of activity, or circabidian
rest-activity patterns.
97-99 The study of schizophrenic
patients by a forced desynchrony experiment revealed
an abnormal circadian propensity for sleep suggesting a
disturbed circadian regulation of sleep.
100Another study
reported desynchronization of CBT, pulse and blood
pressure rhythms.
101 The analysis of melatonin secretion
demonstrated blunted circadian variation.
102-104 Others
have reported phase advances of prolactin, melatonin
and tryptophan.
105
Evidence linking circadian clock gene polymorphisms
or deregulation with schizophrenia is limited. In one
study, SNP analysis of the CLOCK gene demonstrated
that the T3111C polymorphism showed a transmission
bias in a sample of 145 Japanese schizophrenic subjects
relative to healthy controls.
106The authors suggested that
this polymorphism, associated with aberrant dopamin-
ergic transmission to the SCN may underlie the patho-
physiology of schizophrenia.Since dopaminergic signal-
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increased CLOCK:BMAL1 activity,
107 this provides an
interesting link between the dopaminergic hypothesis of
schizophrenia and circadian abnormalities in these
patients. Post-mortem studies have shown decreased
expression of the PER1 mRNA in the temporal lobe of
schizophrenic subjects compared with age-matched nor-
mal controls.
108 Associations of PER3 and TIMELESS
have also been found with schizophrenia/schizoaffective
disorder, as well as with bipolar disorder.
77 The associa-
tion with PER3 is interesting, given the evidence of a
relationship between PER3 with DSPD and evening
chronotype. However, the function of TIMELESS in
mammals is not yet clear,
109 making it difficult to inter-
pret this finding. Finally, the CRY1 gene was hypothe-
sized to be a candidate gene for schizophrenia based on
its location near a linkage hotspot for schizophrenia on
chromosome 12q24.
110 The fact that CRY1 is expressed
in dopaminergic cells in the retina and that its expres-
sion influences the effects of psychoactive drugs lends
further supports to this hypothesis.
Dementia 
Dementia associated with Alzheimer’s disease (AD) has
frequently been associated with psychological distur-
bances that tend to worsen with the progression of the
disease.
111-113 Disturbances of sleep and the rest-activity
cycle are common,including “sundowning,”consisting of
increased wandering,aggression,vocalization,and agita-
tion during the evening, as well as polysomnographic
sleep measures including increased wake after sleep
onset,reduced nocturnal TST,sleep efficiency,and REM
sleep, and increased RL, and electroencephalogram
(EEG) slowing.In addition,these changes in sleep vari-
ables may have diagnostic value as there is some evi-
dence suggesting that sleep disturbances in AD patients
correlate with lower cognitive scores.
114-116 In addition,
changes in circadian rhythms of a number of physiologi-
cal variables have been noted in AD patients including
reduced amplitude and increased fragmentation of the
circadian rhythm of activity, reduced amplitude and
phase delay of the CBT rythm,and reduced amplitude of
the rhythms of melatonin and its metabolite 6-sulfa-
toxymelatonin.
117-120Although AD patients were not sig-
nificantly different from healthy age-matched controls
on all variables,the delay of CBT phase is of particular
note because of a tendency toward phase advance of
CBT in normal aging.
121Anatomical studies suggest that
the changes in the circadian organization of the hormonal
and sleep-activity cycles observed in AD sufferers are due
to fundamental changes in the master clock itself.
122 
Molecular changes in clock gene expression have been
identified in the pineal gland,the brain region that pro-
duces melatonin in response to timing information from
the SCN master clock.Post-mortem pineal tissue from
non-demented subjects shows rhythmic circadian fluctu-
ations of BMAL1,CRY1,PER1,melatonin,melatonin
synthesis,and β1-adrenergic receptor mRNA,the recep-
tor responsible for the circadian control of melatonin lev-
els in the pineal.In contrast,AD patients did not show
any evidence of day-night differences in clock gene
expression,pineal melatonin,melatonin synthesis activ-
ity,or β1-adrenergic receptor mRNA levels,suggesting
malfunction in the circadian signal from the SCN.
123,124
Based on this evidence,it is possible that a weakening of
the signal from the SCN may also be responsible for
changes observed in CBT and the sleep-wake cycle of
AD patients.
Conclusion
Evidence is mounting for a relationship between BPD
and clock genes,particularly with a polymorphism of the
gene CLOCK.Also of considerable interest is the rela-
tionship between mood-stabilizing and antidepressant
treatments and GSK3. Although research linking clock
genes and other mental disorders is still in the early
stages,the findings to date suggest that this approach may
be fruitful, especially in SAD and schizophrenia.
Certainly the potential utility of a genetic screening tool
for the differential diagnosis of mental disorders can not
be underestimated. Clock genes provide a good target
for this type of approach. In addition,clock genes could
open up a new frontier for genetic therapies,as well as
guide the development of new pharmaceuticals. Well-
controlled studies in psychiatric populations must be pur-
sued in order to increase our knowledge of sleep and cir-
cadian rhythm disturbances in mental disorders and on
the genetic basis of these disturbances.❏
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El papel de los genes del reloj circadiano en
la enfermedad mental
El estudio de los mecanismos del reloj molecular en
los trastornos psiquiátricos tiene un interés creciente
ya que la evidencia sugiere que un desajuste entre el
sistema circadiano endógeno y el ciclo sueño-vigilia
podría contribuir al estado clínico de pacientes que
sufren diversos trastornos psiquiátricos. Las altera-
ciones del sueño en el trastorno depresivo mayor
(TDM) están caracterizadas por un aumento en la
latencia de sueño, una pobre eficiencia de sueño,
una reducción de la latencia para el primer episodio
de sueño de movimientos oculares rápidos (MOR) y
un despertar matinal precoz, pero existe escasa evi-
dencia para explicar el papel de los genes del reloj
circadiano en el TDM. También es escasa la informa-
ción sobre los genes del reloj en la ansiedad. En opo-
sición, se ha acumulado una importante cantidad de
evidencia en pacientes con trastorno afectivo bipo-
lar (TAB) la que sugiere un trastorno del ritmo circa-
diano, especialmente un avance de éste y alteracio-
nes de la latencia del sueño MOR estado
dependientes. Gran parte de la investigación acerca
del papel de los genes del reloj en el TAB se ha cen-
trado en el polimorfismo de CLOCK; pero GSK3,
blanco del litio, también puede tener un papel sig-
nificativo. Además se postula que un cambio de fase
circadiana puede contribuir a la fisiopatología del
trastorno afectivo estacional invernal (TAE). Al pare-
cer ciertas combinaciones de alelos de NPAS2, PER3,
y BMAL1 contribuyen al riesgo de un TAE. En la
esquizofrenia crónica se ha observado insomnio y
reducción de la eficiencia del sueño. Los estudios
genéticos han encontrado asociaciones con CLOCK,
PER1, PER3, y TIMELESS. Los cambios circadianos y del
sueño asociados con la demencia de la Enfermedad
de Alzheimer sugieren un cambio funcional en el
reloj maestro circadiano de acuerdo con estudios
postmortem de la expresión génica del reloj en el
cerebro. 
Rôle des gènes de l’horloge circadienne dans
la maladie mentale
L’intérêt grandissant de l’étude des mécanismes
moléculaires de l’horloge dans les troubles psy-
chiatriques s’explique par les données qui indiquent
une mauvaise synchronisation entre le système cir-
cadien endogène et le cycle veille-sommeil lors de
ces troubles et par l’hypothèse que ceci jouerait un
rôle dans l’état clinique des patients. L’allongement
du temps d’endormissement, un sommeil moins
réparateur, une diminution de la latence du pre-
mier épisode de sommeil paradoxal et un réveil
matinal précoce sont caractéristiques des perturba-
tions du sommeil dans les troubles dépressifs
majeurs (TDM). Le rôle des gènes de l’horloge cir-
cadienne reste cependant mal défini dans les TDM
et dans l’anxiété. En revanche, un trouble du
rythme circadien chez les patients atteints de trou-
bles bipolaires (TB) semble exister, du type d’avance
du rythme circadien et d’altérations de la latence
du sommeil paradoxal en relation avec l’état patho-
logique. La recherche sur le rôle des gènes de l’hor-
loge dans les TB a surtout porté sur un polymorp-
hisme du gène CLOCK, mais le GSK3, cible du
lithium, pourrait aussi jouer un rôle significatif. La
possibilité d’un décalage de phase des rythmes cir-
cadiens pourrait également intervenir dans la phy-
siopathologie du trouble affectif saisonnier hiver-
nal (TAS). Certaines combinaisons d’allèles des
gènes NPAS2, PER3, et BMAL1 semblent contribuer
au risque de TAS. Dans la schizophrénie, des trou-
bles du sommeil comprenant insomnie et diminu-
tion de l’efficacité du sommeil sont présents. Des
études génétiques ont trouvé des associations avec
les gènes CLOCK, PER1, PER3, et TIMELESS. Des étu-
des postmortem de l’expression des gènes de l’hor-
loge dans le cerveau soutiennent l’hypothèse d’a-
nomalies fonctionnelles de l’horloge circadienne
lors des modifications circadiennes et du sommeil
associées à la maladie d’Alzheimer.
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